1. Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1. (September 2019) Authors: Cheah, Pike See; Prabhakar, Shilpa; Zhang, Xuan; Zinter, Max; Gianatasio, Maria; Bronson, Roderick; Kwiatkowski, David; Stemmer-Rachamimov, Anat; Maguire, Casey; Sena-Esteves, Miguel; Tannous, Bakhos; Breakefield, Xandra Journal: IBRO reports Issue: Volume 6(2019)Supplement Page Start: S504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy. (25th September 2018) Authors: Carvalho, Litia A; Teng, Jian; Fleming, Renata L; Tabet, Elie I; Zinter, Max; de Melo Reis, Ricardo A; Tannous, Bakhos A Journal: Journal of the National Cancer Institute Issue: Volume 111:Number 3(2019) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗